Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Real-Time Nudges to Physicians Help Reduce Clinical Waste in Hospitals with G. T. LaBorde IllumiCare
Apr 24, 2025
G.T. LaBorde, CEO and Co-Founder of IllumiCare, focuses on reducing hospital clinical waste. Doctors often make decisions about tests, medications, and procedures without knowing the actual cost to the hospital and the patient. The IllumiCare platform aims to nudge doctors to make cost-effective decisions without compromising the quality of patient care by providing cost information and clinical guidance at the point of care. Another benefit is the reduction in overtesting and overprescribing, supporting efforts to improve patient safety..
G.T. explains, "When doctors make decisions about what test to order and what medications to prescribe, particularly in the inpatient setting, they have no idea what the cost is. They don't know the relative cost of one drug or another, and it's not a knock on doctors. It's very difficult to know because there are, in our average hospital across hundreds of hospitals, something like 2,000 different medications on the formulary that are available to order if you're a provider."
"We self-impose a limit, on average, taking only 60 seconds of a provider's attention a day. We calculate when we nudge somebody, when we present something in their workflow, how much time is it on the screen? And it comes down to 60 seconds a day of attention that we take. So we take great pride in how much technology we use to figure out when not to say something or not. We try to figure out the person most likely to take action, and is this information germane to this person for this patient, such that there's a high probability they'll take action? And we measure how frequently people take the action we recommend, and it's several times higher than similar alerts within the electronic medical record."
#IllumiCare #ValueBasedCare #VBC #HealthcareInnovation #ClinicalDecisionSupport #HealthIT #HospitalIT #EHR
